0.830
0.02 (2.47%)
| Previous Close | 0.810 |
| Open | 0.845 |
| Volume | 15,204 |
| Avg. Volume (3M) | 27,170 |
| Market Cap | 126,473,736 |
| Price / Earnings (Forward) | 34.36 |
| Price / Sales | 0.720 |
| Price / Book | 1.09 |
| 52 Weeks Range | |
| Earnings Date | 25 Aug 2021 |
| Profit Margin | -17.84% |
| Operating Margin (TTM) | 1.18% |
| Diluted EPS (TTM) | -0.190 |
| Quarterly Revenue Growth (YOY) | 6.00% |
| Total Debt/Equity (MRQ) | 52.94% |
| Current Ratio (MRQ) | 0.940 |
| Operating Cash Flow (TTM) | 11.95 M |
| Levered Free Cash Flow (TTM) | 11.50 M |
| Return on Assets (TTM) | 0.81% |
| Return on Equity (TTM) | -24.66% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (AU) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bearish | Mixed | |
| Stock | TRAJAN GRO FPO [TRJ] | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -2.0 |
| Average | -1.00 |
|
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental sample. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and Consumables that includes parts, supplies, components and consumable products across the world. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA). |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Core |
| % Held by Insiders | 58.24% |
| % Held by Institutions | 25.23% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |